Insider Transactions in Q3 2021 at Cortexyme, Inc. (CRTX)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 17
2021
|
Christopher P. Lowe Interim CEO, COO & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+33.33%
|
$60,000
$2.23 P/Share
|
|
Aug 16
2021
|
Christopher P. Lowe Interim CEO, COO & CFO |
SELL
Open market or private sale
|
Direct |
22,000
-10.22%
|
$2,112,000
$96.35 P/Share
|
|
Aug 16
2021
|
Christopher P. Lowe Interim CEO, COO & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
22,000
+29.73%
|
$44,000
$2.23 P/Share
|
|
Aug 16
2021
|
Margaret Mc Loughlin |
SELL
Open market or private sale
|
Direct |
6,000
-70.28%
|
$576,000
$96.62 P/Share
|
|
Aug 16
2021
|
Margaret Mc Loughlin |
BUY
Exercise of conversion of derivative security
|
Direct |
6,000
+50.0%
|
$102,000
$17.0 P/Share
|
|
Aug 10
2021
|
Michael J. Detke Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
10,000
-100.0%
|
$1,000,000
$100.0 P/Share
|
|
Aug 10
2021
|
Michael J. Detke Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+50.0%
|
$20,000
$2.23 P/Share
|
|
Jul 07
2021
|
Michael J. Detke Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
17,400
-52.94%
|
$957,000
$55.25 P/Share
|
|
Jul 07
2021
|
Michael J. Detke Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
17,400
+50.0%
|
$34,800
$2.23 P/Share
|
|
Jul 06
2021
|
Michael J. Detke Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
40,861
-91.9%
|
$2,206,494
$54.12 P/Share
|
|
Jul 06
2021
|
Michael J. Detke Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,600
+23.57%
|
$25,200
$2.23 P/Share
|